UNC0379 10 mg | 99.45%
TargetMol
UNC0379 is a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.
More Information Supplier PageUNC0379
Search Results
UNC0379 100 mg | 99.45%
TargetMol
UNC0379 is a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.
More Information Supplier PageUNC0379
Carprofen 100 mg | Purity Not Available
TargetMol
Carprofen is a propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities.
More Information Supplier PageCarprofen
SGI-1027 50 mg | 99.18%
TargetMol
SGI-1027 (DNA Methyltransferase Inhibitor II) is an effective and selective inhibitor of DNA methyltransferase (DNMT). The IC50 of SGI-1027(SGI1027) against DNMT1, DNMT3A, and DNMT3B are 6, 8, 7.5 μM, respectively.
More Information Supplier PageSGI-1027
Carprofen 200 mg | Purity Not Available
TargetMol
Carprofen is a propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities.
More Information Supplier PageCarprofen
Asciminib 50 mg | 97.93%
TargetMol
Asciminib (ABL001) is a potent and selective Bcr-Abl inhibitor (Kd: 0.5–0.8nM).
More Information Supplier PageAsciminib
Asciminib 25 mg | 97.93%
TargetMol
Asciminib (ABL001) is a potent and selective Bcr-Abl inhibitor (Kd: 0.5–0.8nM).
More Information Supplier PageAsciminib
Asciminib 10 mg | 97.93%
TargetMol
Asciminib (ABL001) is a potent and selective Bcr-Abl inhibitor (Kd: 0.5–0.8nM).
More Information Supplier PageAsciminib
Asciminib 5 mg | 97.93%
TargetMol
Asciminib (ABL001) is a potent and selective Bcr-Abl inhibitor (Kd: 0.5–0.8nM).
More Information Supplier PageAsciminib
Asciminib 2 mg | 97.93%
TargetMol
Asciminib (ABL001) is a potent and selective Bcr-Abl inhibitor (Kd: 0.5–0.8nM).
More Information Supplier PageAsciminib